- Dec 11, 2015
Myeloma Canada: Patient Handbook - Understanding Your Blood and Blood Tests
Myeloma Canada: Patient Handbook - Understanding Your Blood and Blood Tests https://myeloma.ca/pixms/uploads/serve/ckeditor/understanding...
109
- Dec 11, 2015
Myeloma UK - Myeloma Animations Series: Clonal evolution: the changing nature of myeloma
Myeloma UK - Myeloma Animations Clonal evolution: the changing nature of myeloma Learn More: https://www.myeloma.org.uk/
117
- Dec 10, 2015
NCT02561962: A Phase 1 Study in Subjects With Relapsed or Refractory Multiple Myeloma
NCT02561962: A Phase 1 Study in Subjects With Relapsed or Refractory Multiple Myeloma A Phase 1 Study in Subjects With Relapsed or...
158
- Dec 10, 2015
NCT02465060: Phase 2: Targeted Therapy Directed by Genetic Testing in Treating Patients With RRMM
NCT02465060: phase 2: Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas,...
171
- Dec 10, 2015
FDA Approved for RRMM: Pomalidomide (Pomalyst) + Dexamethasone
April 23, 2015; SUMMIT, N.J.--(BUSINESS WIRE)-- Celgene Corporation (NASDAQ:CELG) today announced it has fulfilled the accelerated...
79
- Dec 9, 2015
NCT02519452: Phase 1 - Daratumumab + Recombinant Human Hyaluronidase (rHuPH20) RRMM - PAVO Study
MMY1004 (PAVO) Study RRMM The purpose of the study is to evaluate the pharmacokinetics and safety from the mixture of daratumumab and...
289